Logo-bi
BioImpacts. 2022;12(6): 501-513. doi: 10.34172/bi.2022.23733
PMID: 36644544        PMCID: PMC9809140

Original Research

Changing the daily injection of glatiramer acetate to a monthly long acting product through designing polyester-based polymeric microspheres

Fatima Molavi 1 ORCID, Mohammad Barzegar-Jalali 1 ORCID, Hamed Hamishehkar 2 * ORCID

Cited by CrossRef: 0


1- DESNITA R, NOVIANA E, ZAI K, SAIFULLAH SULAIMAN T. AN UP-TO-DATE REVIEW: MICROSPHERES AS A NEW DRUG DELIVERY SYSTEM. Int J App Pharm. 2023;:82 [Crossref]
2- Farahmand D, Mehrabi M, Eidi A. Enhancing Drug Delivery of Glatiramer Acetate Through In Vitro Development of Controlled-Release Nanoliposomes: Investigating Drug Release Kinetics and Cytotoxic Effects. Jundishapur J Nat Pharm Prod. 2024;19(4) [Crossref]
3- Shobeirean A, Attar H, Varshochian R, Rezvanfar M. Glatiramer acetate in situ forming gel, a new approach for multiple sclerosis treatment. DARU J Pharm Sci. 2024;32(2):649 [Crossref]


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge